The chip maker’s results are unlikely to be much of a catalyst for the stock as investors look forward to the GTC in March, one analyst says
Trending
- Roche chairman still expects diagnostics hit from US tariffs
- Regulatory Capital: Interagency FAQs on Tokenized Securities
- Pi Network’s PI Taps 3-Month High, Bitcoin (BTC) Fights for $68K: Weekend Watch
- Is Amazon Stock a Long-Term Buy?
- Crypto Wallets Are the New Bloomberg Terminal for Crypto-Native Capital Flows
- Costco Wholesale: Buy Now, Get Paid Later as Cash and Returns Build
- What Is the Required Minimum Distribution (RMD) for a $500,000 Retirement Account?
- Fed’s Waller on War-Related Inflation, Jobs, Private Credit
Saturday, March 7
